Integration of Retroviruses: A Fine Balance between Efficiency and Danger
Open Access
- 25 January 2005
- journal article
- perspective
- Published by Public Library of Science (PLoS) in PLoS Medicine
- Vol. 2 (1) , e10
- https://doi.org/10.1371/journal.pmed.0020010
Abstract
Since retroviruses can integrate a copy of their DNA into the host cell DNA, they are good vectors for gene therapy. But such vectors also have oncogenic potential.Keywords
This publication has 9 references indexed in Scilit:
- Distinct Genomic Integration of MLV and SIV Vectors in Primate Hematopoietic Stem and Progenitor CellsPLoS Biology, 2004
- Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site PreferencesPLoS Biology, 2004
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003
- Transcription Start Regions in the Human Genome Are Favored Targets for MLV IntegrationScience, 2003
- Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cellsBlood, 2002
- HIV-1 Integration in the Human Genome Favors Active Genes and Local HotspotsCell, 2002
- Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative ConditioningScience, 2002
- Murine Leukemia Induced by Retroviral Gene MarkingScience, 2002
- Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 DiseaseScience, 2000